Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
Public ClinicalTrials.gov record NCT04891289. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase II Study of Systemic Chemotherapy With or Without HAI FUDR/Dexamethasone in Patients With Unresectable Intrahepatic Cholangiocarcinoma
Study identification
- NCT ID
- NCT04891289
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Enrollment
- 164 participants
Conditions and interventions
Conditions
Interventions
- Dexamethasone Drug
- Floxuridine (FUDR) Drug
- Gemcitabine Drug
- Implanted Medical Device Device
- Oxaliplatin Drug
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 6, 2021
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
- Last update posted
- Apr 21, 2026
2021 – 2027
United States locations
- U.S. sites
- 10
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Heart, Lung, and Blood Institute (NIH) (Data Collection Only) | Bethesda | Maryland | 20824 | Recruiting |
| Washington University (Data Collection Only) | St Louis | Missouri | 63110 | Recruiting |
| Memorial Sloan Kettering Basking Ridge - Limited Protocol Activities | Basking Ridge | New Jersey | 07920 | Recruiting |
| Memorial Sloan Kettering Monmouth - Limited Protocol Activities | Middletown | New Jersey | 07748 | Recruiting |
| Memorial Sloan Kettering Bergen - Limited Protocol Activities | Montvale | New Jersey | 07645 | Recruiting |
| Memorial Sloan Kettering Commack - Limited Protocol Activities | Commack | New York | 11725 | Recruiting |
| Memorial Sloan Kettering Westchester - Limited Protocol Activities | Harrison | New York | 10604 | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Recruiting |
| Memorial Sloan Kettering Nassau - Limited Protocol Activities | Uniondale | New York | 11553 | Recruiting |
| Duke University (Data Collection Only) | Durham | North Carolina | 27710 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04891289, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04891289 live on ClinicalTrials.gov.